Biology Reference
In-Depth Information
64. Amadesi S, Moreau J, Tognetto M, Springer J, Trevisani M, Naline E, et al. NK1 recep-
tor stimulation causes contraction and inositol phosphate increase in medium-size human
isolated bronchi. Am J Respir Crit Care Med 2001;163:1206-11.
65. Hall AK, Barnes PJ, Meldrum LA, Maclagan J. Facilitation by tachykinins of neuro-
transmission in guinea-pig pulmonary parasympathetic nerves. Br J Pharmacol 1989;
97:274-80.
66. Colasurdo GN, Loader JE, Graves JP, Larsen GL. Modulation of acetylcholine release in
rabbit airways
in vitro
. Am J Physiol Lung Cell Mol 1995;268:L432-37.
67. Joos GF, Pauwels RA, Van Der Straeten ME. The effect of oxitropium bromide on neuro-
kinin A-induced bronchoconstriction in asthmatics. Pulm Pharmacol 1988;1:41-45.
68. Black JL, Johnson RA, Alouan L, Armour CL. Neurokinin A with K channel block-
ade potentiates contraction to electrical stimulation in human bronchus. Eur J Pharmacol
1990;180:311-17.
69. D'Agostino G, Erbelding D, Kilbinger H. Tachykinin NK(2) receptors facilitate acetyl-
choline release from guinea-pig isolated trachea. Eur J Pharmacol 2000;396:29-32.
70. Cross LJM, Heaney LG, Ennis M. Further characterisation of substance P induced
histamine release from human bronchoalveolar lavage mast cells. Inflamm Res
1996;45:S11-2.
71. Joos GF, Pauwels RA. The
in vivo
effect of tachykinins on airway mast cells in the rat.
Am Rev Respir Dis 1993;148:922-26.
72. Mousli M, Bronner C, Landry Y, Bockaert J, Rouot. B. Direct activation of GTP-binding
regulatory proteins (G-proteins) by substance P and compound 48/80. FEBS Lett 1990;
259:260-62.
73. Krumins SA, Broomfield CA. C-terminal substance-P fragments elicit histamine release
from a murine mast cell line. Neuropeptides 1993;24:5-10.
74. Germonpré PR, Joos GF, Everaert E, Kips JC, Pauwels RA. Characterization of neuro-
genic inflammation in the airways of two highly inbred rat strains. Am J Respir Crit Care
Med 1995;152:1796-804.
75. Mutoh T, Bonham AC, Joad LJ. Substance P in the nucleus of the solitary tract aug-
ments bronchopulmonary C fiber reflex output. Am J Physiol Regul Integr Comp Physiol
2000;279:R1215-23.
76. Advenier C, Lagente CV, Boichot E. The role of tachykinin receptor antagonists in the pre-
vention of bronchial hyperresponsiveness, airway inflammation and cough. Eur Respir J
1997;10:1892-906.
77. Daoui S, Cognon C, Naline E, Edmonds-Alt X. Involvement of tachykinin NK3 recep-
tors in citric acid-induced cough and bronchial responses in guinea pigs. Am J Respir Crit
Care Med 1998;158:42-48.
78. Girard V, Naline E, Vilain P, Emonds-Alt X, Advenier C. Effect of the two tachykinin
antagonists, SR 48968 and SR 140333, on cough induced by citric acid in the unanaesthe-
tized guinea pig. Eur Respir J 1995;8:1110-14.
79. Moreaux B, Nemmar A, Vincke G, Halloy D, Beerens D, Advenier C, et al. Role of sub-
stance P and tachykinin receptor antagonists in citric acid-induced cough in pigs. Eur J
Pharmacol 2000;408:305-12.
80. Kohrogi H, Graf PD, Sekizawa K, Borson DB, Nadel JA. Neutral endopeptidase inhibitors
potentiate substance P- and capsaicin-induced cough in awake guinea pigs. J Clin Invest
1988;82:2063-68.
81. Bolser DC, DeGennaro FC, O'Reilly S, McLeod RL, Hey JA. Central antitussive activity
of the NK1 and NK2 tachykinin receptor antagonists, CP-99,994 and SR 48968, in the
guinea-pig and cat. Br J Pharmacol 1997;121:165-70.
